On July 24, 2020, President Trump signed four Executive Orders to lower drug prices. Medicare Compliance Solutions (MCS) will try to unpack these measures .
On June 24, 2020, the Centers for Medicare & Medicaid Services (CMS) released an alert via HPMS to Medicare Advantage Prescription Drug Plan
CMS Releases Contract Year (CY) 2020 Final Program Audit Protocols for Medicare-Medicaid Plans (MMP)
CMS issued draft 2020 MMP Audit protocols on January 2, 2020 and allowed the industry a 30-day comment period. On January 9, 2020, the CCQIPE Supplemental Questionnaire was provided for comment
30-Day Comment Period Underway for Medicare Part C and Part D Program Audit and Industry-Wide Part C Timeliness Monitoring Project (TMP) Protocols
CMS issued proposed Medicare Part C and Part D Program Audit and Industry-Wide Part C Timeliness Monitoring Project (TMP) Protocols on December 6, 2019 and allowed a 60-day period for public comments.
Medicare Compliance Solutions hopes you are staying safe during this challenging time.
Hurry and wait, hurry and wait. First, CMS released an announcement on 12/27/19 (get ready!) regarding the CMS program audits ……
Medicare Compliance Solutions hopes you are staying safe during this challenging time. So much is happening, changing, confusing.
CMS continues to take critical steps and issue important guidance on the unfolding pandemic. Unprecedented flexibilities have been extended in the healthcare space to give providers necessary resources and support to meet the care delivery demands
As fear for the pandemic caused by the coronavirus (or COVID 19) continues, some questions inevitably come to the fore. Medicare Compliance Solution would like to provide you with the below information for your Call Center or Client Support team as it relates to coverage for treatment of the coronavirus infection.
As the nation faces the COVID-19 pandemic, CMS has taken an historic number of actions to ensure that health plans, providers, and others in the Medicare community are provided with the infrastructure,
On February 28, 2020, the Centers for Medicare & Medicaid Services (CMS) published results of the most recent Quarterly Drug Trend Analysis for the period of April 1, 2019 to September 30, 2019.
Every year since the inception of the Medicare Advantage (MA) program, the Centers for Medicare & Medicaid Services (CMS) announces methodological changes to the program via HPMS releases.
In 2011, the Medicare-Medicaid Coordination Office (MMCO) announced the creation of demonstration projects to support improvements in the quality and cost of care for Medicare-Medicaid
In February 2019, CMS released the long-awaited updates to Chapter 13 of the Medicare Managed Care Manual and Chapter 18 of the Medicare Prescription Drug Benefit Manual
Polypharmacy is common among older adults, according to a New York Times article published on December 16, 2019. Individuals aged 65–69 years take an average of 15 prescriptions a year,
After years of intense oversight of Medicare Advantage (MA) and Part D plans (plans) by CMS, those same plans have
Confident that your Organization is compliant with Medicare Parts C and D Program Requirements? Ran out of time to conduct a mock CMS-audit of operational areas?